Dana has over 16 years' experience with DKP, and currently serves as DKP's Government Payer Liaison where she oversees research, analysis, and implications of state and federal health policy and regulatory initiatives from CMS, Medicare, and Medicaid - particularly those that affect access and reimbursement for branded specialty drugs and biologicals.
She interacts directly with Medicare administrative contractor Medical Directors and policy staff and Medicaid medical policy and pharmacy staff regarding coverage, coding, payment and access issues for new and established products. Additionally, Dana coordinates execution for capture of payer-specific information in the proprietary DKP Compass™ database, which subsequently provides reporting of drug status and reimbursement trending for our clients.
Dana’s expertise in payer knowledge was developed from in-depth work on Medicare and Medicaid, and working with Medicare medical directors, policy analysts, and state Medicaid agency medical directors, pharmacy administrators, and policy staff to facilitate coverage of new FDA-approved physician injectable and self-administered drugs and biologics.
Dana graduated Phi Beta Kappa from Indiana University with a Bachelor of Arts degree. She is also certified as a Managed Healthcare Professional (MHP®) through the Insurance Education Program at America’s Health Insurance Plans (AHIP).